Inside oncology’s research boom

Drugmakers and, largely, the FDA argue that the medicines now being reviewed are different than the chemotherapies and blunter interventions of the past. This is having consequences for how clinical trials are being run, and for how much money drugmake…

LGBTQ+ and the future of CX

Gain an understanding of how consumers – both those identifying as LGBTQ+ and not – experience content, and the implications of these findings for brand growth, now and in the future.Request Free!

Typologies Report 2022

The Elliptic Typologies report is designed to equip governance, risk and compliance professionals with the knowledge and insights needed to proactively and practically:   Identify specific money laundering and terrorist financing risks De…

Secure Your Data Mesh Architecture on AWS

The criticality of becoming a data-driven enterprise is a given. But there are multiple data, security and governance approaches to get there. Which should you choose? Learn the challenges of implementing a Data Lake and the benefits of a modern D…